Evidence map›Paper›PMID 32297930›Full record

ArticleThe Journal of clinical endocrinology and metabolism2020

HbA1c and Diabetes: Mismatches and Misclassifications.

Mary Rhee

Abstract readComment
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Mary RheeEmory University School of Medicine, Department of Medicine, Division of Endocrinology, Metabolism and Lipids, Atlanta, GA.

Funding

Glycemia Reduction Approaches in Diabetes: A comparative effectiveness studyU01DK098246 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI KRAUSE-STEINRAUF, HEIDI, LACHIN, JOHN M · 2012 to 2022
$238.9M
Translational Research Core - Engagement and Behavior ChangeP30DK111024 · NIDDK · EMORY UNIVERSITY · PI Mohammed Kumail Ali · 2016 to 2026
$13.4M
Vitamin D for Type 2 Diabetes (D2D trial)U34DK091958 · NIDDK · TUFTS MEDICAL CENTER · PI PITTAS, ANASTASSIOS G · 2011 to 2012
$792k
Latent tuberculosis infection and risk of type 2 diabetes mellitus in US veteransR03AI133172 · NIAID · GEORGIA STATE UNIVERSITY · PI MAGEE, MATTHEW JAMES · 2018 to 2019
$158k
Diabetic Complications and Genetic Variants in the Million Veterans ProgramI01CX001737 · VA · VETERANS HEALTH ADMINISTRATION · PI PHILLIPS, LAWRENCE S · 2019 to 2023
–
Neuroprotective strategies for retinopathy and cognition in diabetesIK2RX002928 · VA · VETERANS HEALTH ADMINISTRATION · PI ALLEN, RACHAEL STEWART · 2019 to 2023
–
CSRD VA I01 CX001737NIAID NIH HHS R03 AI133172NIDDK NIH HHS P30 DK111024NIDDK NIH HHS U01 DK098246NIDDK NIH HHS U34 DK091958RRD VA IK2 RX002928
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Prediabetic StateBlood GlucoseGlucose Tolerance TestGlycated HemoglobinHumansBlood GlucoseGlycated Hemoglobindiabetesdiagnosisglycated hemoglobin Aglycation gapmisclassificationprediabetesscreening

Identifiers

PMID32297930
PMCPMC7229987

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.